News

Study on the Patented Medicine Prices Review Board (PMPRB) Reforms

CORD submits House Health Committee HESA hearings on disastrous PMPRB drug pricing rules; supposed to lower prices but instead creates barrier to new medicines for rare diseases #Canada4Rare and other life-saving medicines.